Latest California Healthline Stories
Millions Could Lose Medicaid Coverage Under Trump Plan
But block grants face likely resistance from states, poised to lose many millions.
Millones podrían perder el Medicaid bajo el plan de Trump
El mayor riesgo para los beneficiarios del Medicaid proviene de las promesas del presidente electo Donald Trump, y otros republicanos, de revocar la Ley de Cuidado de Salud Asequible (ACA).
Repealing The Affordable Care Act Could Be More Complicated Than It Looks
Republicans will likely chip away at the ACA piecemeal and say they will try to provide a soft exit.
Trump, GOP In Congress Could Use ‘Must-Pass’ Bills To Bring Health Changes
Some “must-pass” health legislation next year could give the new administration a vehicle for proposals that might not be able to clear political or procedural hurdles on their own.
What Would A Public Insurance Option Look Like In California?
California might not need one, UCLA health policy expert Gerald Kominski said in an interview — but he added that it could provide a backstop against potential future retrenchment by private sector health plans in the state’s ACA insurance exchange.
A Golden Ticket That Fast-Tracks A Drug Through The FDA
A voucher awarded to companies that find treatments for rare childhood diseases can be sold to the highest bidder — and then used to speed up approvals for much more common drugs.
Congressman Decries Olympus’ Failure To Warn U.S. Hospitals About Tainted Scopes
U.S. Rep. Ted Lieu (D-Torrance) renews his call for tightened laws that would force manufacturers to notify the U.S. Food and Drug Administration when they issue safety warnings in other countries related to the design and cleaning of their devices.
Urging Openness About Superbug Infections, Doctor Omits Cases In Own Hospital
In a respected medical journal, a specialist advises colleagues on protecting patients but doesn’t mention potential infections from a contaminated scope at his Philadelphia cancer center.
Reforming Federal Oversight Of Medical Devices Won’t Be Easy
Despite dozens of infections from medical scopes, an agreement on how to fix the FDA’s flawed regulation of the device industry remains elusive.